Brokerages expect Ion Geophysical Corp (NYSE:IO) to announce $47.30 million in sales for the current fiscal quarter, Zacks Investment Research reports. Two analysts have issued estimates for Ion Geophysical’s earnings. The highest sales estimate is $48.60 million and the lowest is $46.00 million. Ion Geophysical posted sales of $46.00 million in the same quarter last year, which would indicate a positive year-over-year growth rate of 2.8%. The business is expected to announce its next quarterly earnings results on Wednesday, August 1st.
According to Zacks, analysts expect that Ion Geophysical will report full year sales of $230.25 million for the current fiscal year, with estimates ranging from $224.80 million to $235.70 million. For the next fiscal year, analysts forecast that the business will report sales of $261.35 million per share, with estimates ranging from $255.40 million to $267.30 million. Zacks Investment Research’s sales calculations are an average based on a survey of research firms that cover Ion Geophysical.
Top 5 Growth Stocks To Invest In Right Now: Buffalo Wild Wings Inc.(BWLD)
Advisors' Opinion:- [By Steve Symington]
That's not to say it was a quiet day for every stock on the market. With earnings season ramping up, brewing giant Anheuser-Busch InBev (NYSE:BUD) and restaurant chain Buffalo Wild Wings (NASDAQ:BWLD) served as an exercise in contrast as investors reacted to their respective quarterly reports.
- [By Peter Graham]
A long term performance chart shows Dave & Busters Entertainment tripling in value before falling back while small cap upscale gentlemen's clubs and restaurant owner RCI Hospitality Holdings, Inc (NASDAQ: RICK) began taking off in 2016 and small cap Buffalo Wild Wings (NASDAQ: BWLD) is being acquired by Arby's Restaurant Group:
Top 5 Growth Stocks To Invest In Right Now: Intuitive Surgical Inc.(ISRG)
Advisors' Opinion:- [By Lisa Levin] Gainers vTv Therapeutics Inc. (NASDAQ: VTVT) shares surged 115 percent to $2.56. Seadrill Limited (NYSE: SDRL) gained 77 percent to $0.3935. On Tuesday, a U.S. court approved the company's plan to exit Chapter 11 bankruptcy that includes raising around $1 billion in new debt and equity through a rights offering which will be led by its biggest shareholder. DropCar, Inc. (NASDAQ: DCAR) shares climbed 21.4 percent to $2.3301 after the company issued a preliminary Q1 update on its enterprise automotive business. The company disclosed that Q1 B2B automotive volumes rose 163 percent year-over-year. Teligent, Inc. (NASDAQ: TLGT) shares jumped 19.7 percent to $3.615 following the FDA approval of Clobetasol Propionate Cream USP, 0.05%. IZEA, Inc. (NASDAQ: IZEA) surged 19.1 percent to $2.62. IZEA posted a Q4 net loss of $743,000 on sales of $6.8 million. SunPower Corporation (NASDAQ: SPWR) shares gained 15.2 percent to $9.6180. SunPower announced plans to acquire SolarWorld Americas. LexinFintech Holdings Ltd. (NASDAQ: LX) climbed 10.2 percent to $15.20. CounterPath Corporation (NASDAQ: CPAH) shares rose 8.8 percent to $3.0033. Semiconductor Manufacturing International Corporation (NYSE: SMI) gained 8.2 percent to $6.685 after falling 0.80 percent on Tuesday. Energy XXI Gulf Coast, Inc. (NASDAQ: EGC) shares climbed 7.2 percent to $5.93. Textron Inc. (NYSE: TXT) shares rose 6.7 percent to $63.96 after the company reported stronger-than-expected earnings for its first quarter. Sibanye Gold Limited (NYSE: SBGL) gained 6.5 percent to $3.59 after dropping 4.53 percent on Tuesday. Calithera Biosciences, Inc. (NASDAQ: CALA) rose 6.3 percent to $6.75 after the company disclosed that the FDA has granted Fast Track designation to CB-839 in combination with cabozantinib for treatment of patients with advanced renal cell carcinoma. CSX Corporation (NASDAQ: CSX) gained 6.1 percent to $60.01 after reporting upbeat quarterly earnings
- [By Chris Hill]
But there was more upbeat news elsewhere, with No. 3 airline United Continental (NYSE:UAL) beating on earnings and freight rail titan CSX (NASDAQ:CSX) delivering record first-quarter numbers. Also on the rapid growth train: Intuitive Surgical (NASDAQ:ISRG), whose da Vinci systems are selling at an impressive rate. And speaking of sales of tech products, the guys close out the episode by explaining why it's a win-win that Amazon.com (NASDAQ:AMZN) and Best Buy (NYSE:BBY) are joining forces to sell smart TVs.
- [By Keith Speights]
If you buy stocks that have great business models and you have a long-term perspective, there's no reason to bail out even if a recession is right around the corner. As an example, let's consider Intuitive Surgical (NASDAQ:ISRG), a stock that I own. The company has a razor-and-blades type of business model with its robotic surgical systems and instruments and accessories for those systems.
- [By Stephan Byrd]
Align Technology (NASDAQ: ALGN) and Intuitive Surgical (NASDAQ:ISRG) are both large-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, valuation, analyst recommendations, institutional ownership, profitability, risk and earnings.
- [By Ethan Ryder]
Intuitive Surgical, Inc. (NASDAQ:ISRG)’s share price hit a new 52-week high during trading on Friday . The stock traded as high as $498.06 and last traded at $496.25, with a volume of 13472 shares trading hands. The stock had previously closed at $488.97.
Top 5 Growth Stocks To Invest In Right Now: TrueBlue Inc.(TBI)
Advisors' Opinion:- [By Logan Wallace]
ValuEngine downgraded shares of Trueblue (NYSE:TBI) from a hold rating to a sell rating in a report issued on Friday morning.
Several other research firms have also recently weighed in on TBI. Zacks Investment Research cut shares of Trueblue from a hold rating to a sell rating in a research report on Tuesday, February 12th. BMO Capital Markets decreased their price objective on shares of Trueblue from $26.00 to $24.00 and set a market perform rating for the company in a research report on Monday, February 11th. TheStreet cut shares of Trueblue from a b- rating to a c rating in a research report on Monday, December 31st. Finally, Credit Suisse Group decreased their price objective on shares of Trueblue from $31.00 to $25.00 and set a hold rating for the company in a research report on Tuesday, November 6th. Two equities research analysts have rated the stock with a sell rating and three have given a hold rating to the company. Trueblue presently has an average rating of Hold and a consensus price target of $26.00.
- [By Max Byerly]
Connor Clark & Lunn Investment Management Ltd. lifted its holdings in Trueblue Inc (NYSE:TBI) by 18.2% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 30,550 shares of the business services provider’s stock after purchasing an additional 4,700 shares during the period. Connor Clark & Lunn Investment Management Ltd.’s holdings in Trueblue were worth $823,000 as of its most recent filing with the Securities & Exchange Commission.
- [By Joseph Griffin]
Trueblue Inc (NYSE:TBI) has received a consensus rating of “Hold” from the six brokerages that are currently covering the firm, MarketBeat.com reports. Two investment analysts have rated the stock with a sell recommendation and three have assigned a hold recommendation to the company. The average twelve-month target price among brokerages that have issued a report on the stock in the last year is $27.50.
- [By Motley Fool Transcribers]
TrueBlue Inc (NYSE:TBI)Q4 2018 Earnings Conference CallFeb. 07, 2019, 5:00 p.m. ET
Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:Operator
Top 5 Growth Stocks To Invest In Right Now: MEDIFAST INC(MED)
Advisors' Opinion:- [By Motley Fool Transcribers]
Medifast Inc (NYSE:MED)Q4 2018 Earnings Conference CallFeb. 26, 2019, 4:30 p.m. ET
Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:Operator
- [By Joseph Griffin]
MediBloc (CURRENCY:MED) traded 6.8% lower against the dollar during the 1-day period ending at 15:00 PM Eastern on May 27th. MediBloc has a total market cap of $73.40 million and $743,880.00 worth of MediBloc was traded on exchanges in the last 24 hours. One MediBloc token can currently be purchased for approximately $0.0247 or 0.00000339 BTC on major cryptocurrency exchanges including Bibox, Gate.io and Coinrail. During the last seven days, MediBloc has traded 8.3% higher against the dollar.
- [By Max Byerly]
McCormick & Company, Incorporated (NYSE: MKC) and Medifast (NYSE:MED) are both consumer staples companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, valuation, profitability, analyst recommendations, institutional ownership, risk and dividends.
Top 5 Growth Stocks To Invest In Right Now: Nordstrom Inc.(JWN)
Advisors' Opinion:- [By ]
Cramer and the AAP team say today's weakness is the opportunity they have been patiently waiting for. Their target? Nordstrom (JWN) . Find out what they're telling their investment club members and get in on the conversation with a free trial subscription to Action Alerts PLUS.
- [By Paul Ausick]
One bit of good news for Walmart is that its Sam’s Club warehouse stores scored an 80 to tie for third behind Costco Wholesale Corp. (NASDAQ: COST) at 83 and Nordstrom Inc. (NYSE: JWN) at 81.
- [By Mac Greer]
They have a lot of things in the works. They're kind of throwing some things at the wall and seeing what will stick. They have their Macy's Backstage concept, which is their discount concept. Every retailer has to have one nowadays, like a Nordstrom (NYSE:JWN) Rack, for example. They actually bought a concept store in New York City called Story, which is a store that revamps its inventory every four to eight weeks to try to keep it fresh. That would be some Inventory management job. Their buyers have their work cut out for them. But, interesting. They're trying a lot of different things.
- [By Chris Lange]
Nordstrom Inc. (NYSE: JWN) will reveal its fiscal fourth-quarter results later Thursday. The consensus analyst estimates are $1.42 in EPS and revenue of $4.61 billion. Shares of Nordstrom closed at $44.04 on Friday, while the consensus price target is $52.00. The 52-week range is $43.04 to $67.75.
- [By ]
When it comes to fashion, Nordstrom (JWN) was a surprise pick, along with Macy's (M) which has been investing to fight back against Amazon.
Boss admitted that President Trump and a trade war with China remain a wild card for retailers and that will be something they continue to watch closely.
- [By Chris Lange]
The S&P 500 stock posting the largest daily percentage gain ahead of the close was Nordstrom, Inc. (NYSE: JWN) which traded up about 13% at $59.13. The stock's 52-week range is $37.79 to $59.21. Volume was about 17 million compared to the daily average volume of 2.5 million.
No comments:
Post a Comment